Recombinant Saccharomyces cerevisiae Ubiquitin-like-conjugating enzyme ATG10 (ATG10)

What is the primary function of ATG10 in Saccharomyces cerevisiae?

ATG10 functions as a ubiquitin-like-conjugating enzyme (E2-like enzyme) essential for autophagy in yeast. It catalyzes the conjugation of ATG12 to ATG5, forming a complex critical for autophagosome formation. Research demonstrates that ATG10 is necessary for autophagy flux, with knockout studies confirming its essential role in the autophagic machinery . The protein participates in the early stages of autophagosome biogenesis and influences both autophagosome size and number, making it a central player in maintaining cellular homeostasis through autophagy-mediated degradation and recycling processes.

How do different isoforms of ATG10 influence cellular functions?

Research has identified at least two distinct isoforms of the ATG10 protein with specialized functions. The canonical long isoform participates in traditional autophagy processes, while the non-canonical short isoform (ATG10S) demonstrates distinct effects on cellular processes, particularly in response to viral infection . The long isoform can facilitate viral replication by promoting autophagosome formation and detaining autophagosomes in the cellular periphery, causing impaired autophagy flux. In contrast, ATG10S activates expression of immunity genes and promotes autophagolysosome formation by directing autophagosomes to the perinuclear region where lysosomes gather, leading to enhanced degradation . These functional differences highlight how alternative splicing or post-translational modifications can drastically alter protein function.

What experimental approaches can verify successful ATG10 expression in recombinant yeast strains?

Verification of ATG10 expression in recombinant S. cerevisiae requires multiple complementary approaches. PCR amplification using ATG10-specific primers can confirm successful gene integration, appearing as a distinct band at the expected molecular weight (approximately 1 kb for ATG10) . Western blotting with anti-His antibodies (if using His-tagged constructs) or ATG10-specific antibodies provides protein-level confirmation, with ATG10 appearing in the 35-48 kDa range . Functional verification through autophagy assays, such as the alkaline phosphatase (ALP) assay with the pho8Δ60 mutation, can confirm that the expressed protein maintains catalytic activity. These combined approaches ensure that both the gene integration and functional expression of the protein have been achieved.

How can researchers generate ATG10 knockout strains in Saccharomyces cerevisiae?

Creating ATG10 knockout strains (atg10Δ) requires homologous recombination to replace the ATG10 gene with a selectable marker. The procedure involves:

• Design primers with 40-50 bp homology to regions flanking the ATG10 gene

• Amplify a selection marker (e.g., kanamycin resistance gene) with these primers

• Transform the PCR product into the target yeast strain

• Select transformants on appropriate media containing the selection agent

• Verify correct integration through PCR verification with primers that recognize the junction between the genomic DNA and inserted marker

Researchers should confirm successful knockouts through both genotypic verification (PCR) and phenotypic analysis (impaired autophagy). The WLY176 strain has been successfully used for ATG10 knockout studies, with transformants verified by testing both integration-specific primer sets and wild-type gene primers to confirm complete replacement .

What methods are most effective for measuring ATG10-mediated autophagy activity?

The alkaline phosphatase (ALP) assay provides a quantitative measure of autophagic activity in ATG10 wild-type and mutant strains. This assay utilizes strains carrying the pho8Δ60 mutation, where alkaline phosphatase lacks its signal sequence and can only reach the vacuole through autophagy . The procedure involves:

• Growing yeast cells to log phase in nutrient-rich media

• Inducing autophagy through nitrogen starvation conditions

• Lysing cells with specialized buffer containing PIPES KOH, KCl, KOAc, MgSO4, ZnSO4, and TX-100

• Measuring activated alkaline phosphatase activity spectrophotometrically

• Normalizing to protein concentration through BCA protein assays

Additional methods include monitoring Ape1 processing (a selective autophagy cargo) before and after starvation, providing functional confirmation of ATG10 activity. Using GFP-ATG8 puncta formation assays can also visualize autophagosome formation dynamics in different ATG10 variants .

How should researchers design expression vectors for optimal ATG10 expression in yeast?

Designing expression vectors for ATG10 requires careful consideration of promoters, selection markers, and protein tags. For constitutive expression, the TEF1 or GAP promoters provide strong, consistent expression levels . For inducible systems, the GAL1 promoter allows for controlled expression in response to galactose.

When constructing vectors:

• Select appropriate auxotrophic markers (e.g., URA3, LEU2, HIS3) based on your strain background

• Consider C-terminal tags (His, PA, or GFP) that preserve ATG10 function

• Include multiple cloning sites for flexible construct design

• Ensure proper codon optimization for S. cerevisiae

Novel Δ9 or Δ10 strains with multiple auxotrophies allow for the simultaneous introduction of up to 10 different plasmids, enabling complex experimental designs with multiple components . This approach is particularly valuable for studying ATG10 interactions with other autophagy proteins or for complementation studies with different ATG10 variants.

How does ATG10 interact with the cellular immune response mechanism?

ATG10 serves as a critical link between autophagy and innate immune responses. The short isoform ATG10S activates expression of immune-related genes including IL28A/B, ddx-58, tlr-3, tlr-7, irf-3, and irf-7, all involved in viral RNA detection and response . The mechanism involves:

• Direct interaction between ATG10S and IL28A protein

• IL28A-facilitated autophagosome docking to lysosomes

• Enhanced lysosomal degradation of pathogen components

• Modulation of innate immune signaling cascades

This dual functionality makes ATG10 a promising target for antiviral research, as it demonstrates how a single protein can bridge two critical defense systems: autophagy and immune response. In contrast to ATG10S, the canonical long isoform appears to facilitate viral replication in some contexts, highlighting the complex and sometimes opposing roles of different protein isoforms .

What are the challenges in distinguishing the roles of different ATG10 isoforms experimentally?

Distinguishing between ATG10 isoforms presents several experimental challenges:

• Isoform-specific expression: Creating constructs that express only one isoform requires precise knowledge of alternative splicing sites or post-translational modification patterns

• Functional overlap: Both isoforms participate in autophagy processes, making it difficult to attribute specific outcomes to individual isoforms

• Context-dependent activity: The effects of each isoform may vary depending on cellular conditions and stressors

• Antibody specificity: Developing antibodies that can distinguish between highly similar isoforms requires careful epitope selection

To address these challenges, researchers can employ isoform-specific knockdown approaches, create chimeric proteins with differential tags, or use domain-specific mutations to selectively impair the function of one isoform. CRISPR-Cas9 genome editing offers promising approaches for introducing precise modifications to study isoform-specific functions .

How can ATG10 be utilized in studies of stress response mechanisms in yeast?

ATG10 serves as an excellent model for studying stress response mechanisms because of its central role in autophagy, a key cellular adaptation to various stressors. Researchers can utilize ATG10 in stress studies through:

• Comparative stress assays: Testing the viability and growth patterns of wild-type, atg10Δ, and ATG10-overexpressing strains under various stressors (oxidative, nutritional, temperature)

• Chemical inhibitor studies: Evaluating how chemical inhibitors of autophagy modify cellular responses to stress conditions in an ATG10-dependent manner

• Gene expression analysis: Measuring changes in ATG10 expression levels under different stress conditions to identify regulatory patterns

• Interaction studies: Identifying stress-specific protein interactions using tagged ATG10 variants under different conditions

One concrete application is studying resistance to furfural and hydroxymethylfurfural (HMF), common inhibitors in biofuel production that reduce ethanol productivity in S. cerevisiae. Strains with modified autophagy pathways through ATG10 manipulation could potentially exhibit altered tolerance to these inhibitors, similar to studies with other stress-response genes .

How can CRISPR-Cas9 systems be applied to ATG10 research in Saccharomyces cerevisiae?

CRISPR-Cas9 technology offers precise genome editing capabilities for ATG10 research in yeast:

• Site-specific mutations: Introducing point mutations at specific sites in the ATG10 gene to study structure-function relationships

• Domain swapping: Creating chimeric ATG10 proteins by replacing specific domains with those from homologs

• Isoform manipulation: Editing splicing signals to alter isoform ratios

• Endogenous tagging: Adding reporter tags to the endogenous ATG10 locus without disrupting function

The technique involves designing guide RNAs (gRNAs) targeting specific regions of the ATG10 gene, expressing Cas9 nuclease, and providing donor DNA templates for homology-directed repair. Co-transformation of gRNA plasmid and donor DNA in cells constitutively expressing Cas9 can achieve near 100% donor DNA recombination frequency . This high efficiency allows for rapid screening of multiple ATG10 variants without extensive selection procedures.

What considerations are important when designing ATG10 mutants to study functional domains?

Designing informative ATG10 mutants requires careful consideration of structural and functional domains:

• Conserved motif analysis: Target highly conserved residues across species, particularly within the active site

• Catalytic residues: Modify the catalytic cysteine essential for ubiquitin-like conjugation activity

• Protein-protein interaction domains: Identify and mutate regions responsible for binding to ATG5, ATG12, and other partners

• Regulatory sites: Target potential phosphorylation or ubiquitination sites that might regulate activity

• Isoform-specific regions: Modify regions unique to specific isoforms to distinguish their functions

Researchers should verify mutant expression levels through Western blotting and assess effects on autophagy through established assays like the ALP assay or Ape1 processing tests . Additionally, growth curve analysis comparing wild-type and mutant strains can reveal phenotypic consequences of mutations, particularly under stress conditions.

How can researchers distinguish between direct and indirect effects when manipulating ATG10 expression?

Distinguishing between direct and indirect effects of ATG10 manipulation requires multiple complementary approaches:

• Acute vs. chronic manipulation: Compare results from inducible expression systems (acute effects) with constitutive expression or knockout systems (chronic effects)

• Catalytically inactive mutants: Use catalytic site mutants that maintain protein structure but lack enzymatic activity to separate structural from catalytic roles

• Epistasis analysis: Combine ATG10 manipulations with modifications of downstream factors to determine pathway dependencies

• Temporal analysis: Monitor cellular responses at multiple time points after ATG10 induction or repression

• Rescue experiments: Test whether wild-type ATG10 can restore normal function in knockout strains, and compare with rescue attempts using mutant variants

These approaches help establish causality in complex autophagy pathways where multiple proteins interact in dynamic fashion. For example, growth curve analysis revealed that ATG10 knockout strains showed longer doubling time and lag phase compared to wild-type strains when exposed to inhibitors, directly linking ATG10 to stress response mechanisms .

How does ATG10 function impact cellular resistance to fermentation inhibitors?

ATG10's role in autophagy directly influences cellular resistance to fermentation inhibitors such as furfural and hydroxymethylfurfural (HMF). Research indicates that:

• Autophagy plays a crucial role in removing damaged proteins and organelles during stress conditions

• Furfural (20 mM) and HMF (60 mM) significantly inhibit ethanol productivity in S. cerevisiae

• Exposure to these inhibitors leads to extended lag phases in yeast growth curves

• Strains with impaired autophagy (like atg10Δ) show greater sensitivity to these inhibitors

This knowledge suggests that enhancing ATG10 expression or activity could potentially improve yeast strain tolerance to inhibitors in biofuel production processes. The differential toxicity of furfural and HMF (with HMF being more toxic at 60 mM than furfural at 20 mM) indicates compound-specific stress responses that may involve different autophagy-related pathways .

What insights from yeast ATG10 research translate to understanding human autophagy disorders?

Yeast ATG10 research provides valuable insights into human autophagy disorders due to the high conservation of core autophagy machinery:

• Fundamental mechanisms: The basic conjugation system involving ATG10 is conserved from yeast to humans

• Disease modeling: Mutations analogous to those found in human autophagy disorders can be replicated and studied in yeast

• Drug screening: Yeast systems provide efficient platforms for identifying compounds that modulate autophagy

• Functional conservation: Complementation studies using human ATG10 in yeast atg10Δ strains can verify functional conservation

The dual role of ATG10 in autophagy and immune response is particularly relevant to human diseases at the intersection of these processes, including neurodegenerative disorders, infectious diseases, and cancer . By defining the molecular mechanisms of ATG10 function in yeast, researchers can identify potential therapeutic targets in human disease contexts.

How can ATG10 be utilized in developing improved industrial yeast strains?

ATG10 manipulation offers several approaches for developing industrial yeast strains with enhanced characteristics:

• Stress tolerance: Overexpression of ATG10 or optimized variants may improve cellular resistance to industrial stressors, including ethanol, organic acids, and inhibitory compounds

• Longevity enhancement: Optimizing autophagy through ATG10 modulation could extend the functional lifespan of yeast in industrial fermentations

• Protein production: For recombinant protein production, modulating ATG10 may enhance protein quality control and reduce aggregation

• Metabolic engineering: Integrating ATG10 modifications with existing metabolic engineering strategies could create synergistic improvements

The development of novel plasmid systems allowing the introduction of up to 10 different plasmids into a single strain enables complex engineering approaches, where ATG10 modifications can be combined with other genetic modifications targeting metabolic pathways or stress response mechanisms . This multi-plasmid approach allows for sophisticated strain development strategies previously unattainable with simpler genetic systems.

What emerging technologies will advance ATG10 research in the next decade?

Several emerging technologies are poised to revolutionize ATG10 research:

• Advanced genome editing: Enhanced CRISPR systems with improved specificity and efficiency will enable more precise manipulation of ATG10 and related genes

• Single-cell analysis: Technologies tracking ATG10 dynamics at the single-cell level will reveal population heterogeneity in autophagy responses

• Structural biology advances: Cryo-EM and advanced crystallography will provide detailed structural insights into ATG10 interactions

• Synthetic biology approaches: Designer autophagy systems with engineered ATG10 variants will allow customized cellular responses

• Systems biology integration: Multi-omics approaches will place ATG10 function within comprehensive cellular networks

These technologies will move beyond studying ATG10 in isolation to understanding its integrated role in cellular homeostasis and stress response. The application of artificial intelligence for predicting protein-protein interactions and functional consequences of mutations will accelerate discovery in this field.

What are the most significant unanswered questions regarding ATG10 function in yeast?

Despite significant progress, several critical questions about ATG10 remain unanswered:

• Isoform regulation: How is the expression of different ATG10 isoforms regulated in response to different cellular conditions?

• Non-canonical functions: Does ATG10 have functions outside of the classical autophagy pathway in yeast?

• Substrate specificity: What determines the specificity of ATG10 for its substrates, and can this be engineered?

• Evolutionary adaptation: How has ATG10 function evolved across different yeast species adapted to different environmental niches?

• Interaction networks: What is the complete interactome of ATG10 under different stress conditions?

Addressing these questions will require integrated approaches combining genetics, biochemistry, structural biology, and systems biology. The development of temporal and spatial tracking of ATG10 activity in living cells will be particularly valuable for understanding its dynamic functions.

How might synthetic biology approaches incorporate ATG10 for creating novel cellular functions?

Synthetic biology offers exciting possibilities for incorporating ATG10 into engineered cellular systems:

• Programmable autophagy: Engineering ATG10 variants that respond to specific stimuli could create cells with customized autophagy responses

• Targeted degradation systems: Modified ATG10 could be used to create synthetic degradation pathways for specific cellular components

• Biosensor development: ATG10 activity could be coupled to reporter systems to create biosensors for specific cellular stresses

• Compartmentalization control: Engineered ATG10 variants could help create and regulate synthetic organelles

• Orthogonal autophagy systems: Creating parallel autophagy systems using modified ATG10 proteins could allow for simultaneous but independent degradation pathways

The ability to transform yeast with multiple plasmids (up to 10 in novel Δ10 strains) enables the construction of complex genetic circuits incorporating ATG10 variants alongside other synthetic components . This approach could lead to yeast strains with entirely novel functions not found in nature, with applications in biomanufacturing, biosensing, and fundamental research.